LACK OF EFFECT OF REPEATED ADMINISTRATION OF MILNACIPRAN, A DOUBLE NORADRENALINE AND SEROTONIN REUPTAKE INHIBITOR, ON THE BETA-ADRENOCEPTOR-LINKED ADENYLATE-CYCLASE SYSTEM IN THE RAT CEREBRAL-CORTEX
G. Neliat et al., LACK OF EFFECT OF REPEATED ADMINISTRATION OF MILNACIPRAN, A DOUBLE NORADRENALINE AND SEROTONIN REUPTAKE INHIBITOR, ON THE BETA-ADRENOCEPTOR-LINKED ADENYLATE-CYCLASE SYSTEM IN THE RAT CEREBRAL-CORTEX, Neuropharmacology, 35(5), 1996, pp. 589-593
The effects of subacute administration of the double noradrenaline and
serotonin uptake inhibitor antidepressant, milnacipran, and the tricy
clic antidepressant, imipramine, on radioligand binding to beta-adrene
rgic receptors and on beta-adrenergic agonist-stimulated adenylate cyc
lase activity, in the rat cerebral cortex, have been determined. Rats
were injected intraperitoneally for 21 days with milnacipran (3, 10 or
30 mg/kg/day) or imipramine (10 mg/kg/day). The treatment with milnac
ipran up to 30 mg/kg/day did not modify either the maximum number of [
H-3]CGP-12177 binding sites (B-max) or the equilibrium dissociation co
nstant (K-d) On the other hand, treatment of the rats with 10 mg/kg/da
y imipramine induced a decrease (27%) in B-max [H-3]CGP-12177 binding
sites without affecting the K-d value. Furthermore, milnacipran did no
t affect the stimulation of cAMP production induced by either 30 mu M
isoprenaline, 10 mu M GTP gamma S or 10 mu M forskolin. Under similar
conditions, treatment with imipramine reduced by 70% the isoprenaline-
induced stimulation of cAMP production without affecting that induced
by either GTP gamma S or forskolin. These results demonstrate that, un
like imipramine, subacute administration of milnacipran does not produ
ce any change in beta-adrenoceptor sensitivity in the rat brain cortex
. Copyright (C) 1996 Elsevier Science Ltd.